926. Industry and NGO Perspective
Session: Symposium: Incentivizing Vaccine Innovation
Friday, October 28, 2016: 10:30 AM
Room: 278-282
Mark Feinberg, MD, PhD, FIDSA, International AIDS Vaccine Initiative, New York, NY


M. Feinberg, Merck & Co., Inc.: Consultant and Shareholder , Consulting fee

See more of: Incentivizing Vaccine Innovation
See more of: Symposium
Previous Presentation | Next Presentation >>

Findings in the abstracts are embargoed until 12:01 a.m. CDT, Wednesday Oct. 26th with the exception of research findings presented at the IDWeek press conferences.